FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:695-697 August 26, 1999 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Morris, M. PubMed Citation

To the Editor: In the April 15 issue, Morris et al.¹ and Rose et al.² reported the results of randomized clinical trials comparing radiotherapy and concurrent cisplatin-containing chemotherapy with radiotherapy alone or radiotherapy combined with hydroxyurea for the treatment of cervical cancer. The median durations of radiotherapy in these trials were 58 days and 63 days, respectively. The duration of treatment appeared to be independent of variations in or the absence of chemotherapy from the treatment regimen. In both trials, the intended dose of radiotherapy would optimally have been delivered within 50 days.

For cervical cancer, the rates of local . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Pearcey, R., Miao, Q., Kong, W., Zhang-Salomons, J., Mackillop, W. J. (2007). Impact of Adoption of Chemoradiotherapy on the Outcome of Cervical Cancer in Ontario: Results of a Population-Based Cohort Study. JCO 25: 2383-2388 [Abstract] [Full Text]  
• Pearcey, R., Brundage, M., Drouin, P., Jeffrey, J., Johnston, D., Lukka, H., MacLean, G., Souhami, L., Stuart, G., Tu, D. (2002). Phase III Trial Comparing Radical Radiotherapy With and Without Cisplatin Chemotherapy in Patients With Advanced Squamous Cell Cancer of the Cervix. JCO 20: 966-972 [Abstract] [Full Text]